Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Aging

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Aging in 25 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research Excerpts

ExcerptRelevanceReference
" The present study aimed to evaluate the differential toxic effects of MDMA in adolescent and aged Wistar rats, using doses pharmacologically comparable to humans."1.48Aged rats are more vulnerable than adolescents to "ecstasy"-induced toxicity. ( Barbosa, DJ; Bastos, ML; Capela, JP; Carvalho, F; Costa, VM; Duarte, JA; Duarte-Araújo, M; Feio-Azevedo, R; Fernandes, E; Gomes, S; Marques, F; Pereira, FC; Pita, I; Teixeira-Gomes, A, 2018)
"While hippocampus is a brain region particularly susceptible to the effects of MDMA, the cellular and molecular changes induced by MDMA are still to be fully elucidated, being the dosage regimen, the species and the developmental stage under study great variables."1.42Chronic MDMA induces neurochemical changes in the hippocampus of adolescent and young adult rats: Down-regulation of apoptotic markers. ( García-Cabrerizo, R; García-Fuster, MJ, 2015)
" The 3 highest MDMA dose groups showed reduced locomotor activity during the first 10 min (of 60 min), especially in the PD 1-5 and 6-10 dosing regimens."1.35(+/-)3,4-Methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty. ( Grace, CE; Herring, NR; Schaefer, TL; Skelton, MR; Vorhees, CV; Williams, MT, 2009)

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.00)18.2507
2000's10 (40.00)29.6817
2010's14 (56.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feio-Azevedo, R1
Costa, VM1
Barbosa, DJ1
Teixeira-Gomes, A1
Pita, I1
Gomes, S1
Pereira, FC1
Duarte-Araújo, M1
Duarte, JA1
Marques, F1
Fernandes, E1
Bastos, ML1
Carvalho, F1
Capela, JP1
Montagud-Romero, S1
Daza-Losada, M2
Vidal-Infer, A1
Maldonado, C2
Aguilar, MA3
Miñarro, J3
Rodríguez-Arias, M3
García-Pardo, MP1
Manzanedo, C2
García-Cabrerizo, R2
García-Fuster, MJ2
Frau, L2
Costa, G1
Porceddu, PF2
Khairnar, A1
Castelli, MP1
Ennas, MG1
Madeddu, C1
Wardas, J1
Morelli, M2
Abad, S1
Camarasa, J1
Pubill, D1
Camins, A1
Escubedo, E1
Simola, N1
Skelton, MR3
Schaefer, TL3
Herring, NR2
Grace, CE3
Vorhees, CV3
Williams, MT3
Piper, BJ2
Farelli, JD1
Meyer, JS3
Arias-Cavieres, A1
Rozas, C1
Reyes-Parada, M1
Barrera, N1
Pancetti, F1
Loyola, S1
Lorca, RA1
Zeise, ML1
Morales, B1
Walker, QD1
Morris, SE1
Arrant, AE1
Nagel, JM1
Parylak, S1
Zhou, G1
Caster, JM1
Kuhn, CM1
Adori, C1
Andó, RD1
Szekeres, M1
Gutknecht, L1
Kovács, GG1
Hunyady, L1
Lesch, KP1
Bagdy, G1
Graham, DL1
Braun, AA1
Burns, LN1
Amos-Kroohs, RM1
Llorente-Berzal, A1
Valero, M1
López-Gallardo, M1
Viveros, MP1
Kolyaduke, OV1
Hughes, RN1
Morley-Fletcher, S1
Bianchi, M1
Gerra, G1
Laviola, G1
Reveron, ME1
Monks, TJ1
Duvauchelle, CL1
Vu, HL1
Safain, MG1
Oliver, AJ1
Fisk, JE1
Montgomery, C1
Wareing, M1
Murphy, PN1
Kindlundh-Högberg, AM2
Schiöth, HB2
Svenningsson, P1
Blomqvist, A1
Malki, R1
Broening, HW1
Bowyer, JF1
Slikker, W1
Ali, SF1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress Disorder[NCT03752918]Phase 120 participants (Anticipated)Interventional2024-01-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

25 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Aging

ArticleYear
Aged rats are more vulnerable than adolescents to "ecstasy"-induced toxicity.
    Archives of toxicology, 2018, Volume: 92, Issue:7

    Topics: Aging; Animals; Brain; Dopamine; Fever; Heart; Liver; Male; N-Methyl-3,4-methylenedioxyamphetamine;

2018
The novelty-seeking phenotype modulates the long-lasting effects of intermittent ethanol administration during adolescence.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Adolescent; Aging; Animals; Anxiety; Behavior, Animal; Cocaine; Ethanol; Exploratory Behavior; Human

2014
Effects of acute social stress on the conditioned place preference induced by MDMA in adolescent and adult mice.
    Behavioural pharmacology, 2014, Volume: 25, Issue:5-6

    Topics: Aging; Animals; Anxiety; Conditioning, Psychological; Corticosterone; Dominance-Subordination; Dose-

2014
Chronic MDMA induces neurochemical changes in the hippocampus of adolescent and young adult rats: Down-regulation of apoptotic markers.
    Neurotoxicology, 2015, Volume: 49

    Topics: Aging; Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Body Temperature; Body Weig

2015
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.
    Journal of neurochemistry, 2016, Volume: 136, Issue:1

    Topics: Age Factors; Aging; Animals; Caffeine; Dopaminergic Neurons; Drug Synergism; Inflammation; Male; Mic

2016
Adaptive Plasticity in the Hippocampus of Young Mice Intermittently Exposed to MDMA Could Be the Origin of Memory Deficits.
    Molecular neurobiology, 2016, Volume: 53, Issue:10

    Topics: Aging; Animals; Biomarkers; Brain-Derived Neurotrophic Factor; Hippocampus; Male; Memory; Memory Dis

2016
Comparative effects of amphetamine-like psychostimulants on rat hippocampal cell genesis at different developmental ages.
    Neurotoxicology, 2016, Volume: 56

    Topics: Age Factors; Aging; Amphetamine; Animals; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cent

2016
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain.
    Neurotoxicology, 2016, Volume: 56

    Topics: Aging; Analysis of Variance; Animals; Body Temperature; CD11b Antigen; Crowding; Disease Models, Ani

2016
Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats.
    Psychopharmacology, 2009, Volume: 204, Issue:2

    Topics: Aging; Animals; Anxiety; Body Weight; Cues; Female; Hallucinogens; Learning; Lighting; Maze Learning

2009
Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats.
    Developmental neuroscience, 2009, Volume: 31, Issue:1-2

    Topics: Aging; Animals; Animals, Newborn; Brain Chemistry; Brain-Derived Neurotrophic Factor; Cerebral Corte

2009
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty.
    Developmental neuroscience, 2009, Volume: 31, Issue:1-2

    Topics: Aging; Animals; Animals, Newborn; Body Weight; Cues; Dose-Response Relationship, Drug; Female; Hallu

2009
MDMA ("ecstasy") impairs learning in the Morris Water Maze and reduces hippocampal LTP in young rats.
    Neuroscience letters, 2010, Jan-29, Volume: 469, Issue:3

    Topics: Aging; Animals; CA1 Region, Hippocampal; Central Nervous System Stimulants; Dose-Response Relationsh

2010
Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:1

    Topics: Aging; Amphetamines; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Dopamine Uptake Inhibitor

2010
Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in Dark Agouti rat.
    The Journal of comparative neurology, 2011, Aug-15, Volume: 519, Issue:12

    Topics: Adolescent; Adult; Aging; Animals; Body Temperature; Body Weight; Brain; Brain-Derived Neurotrophic

2011
Distinct periods of developmental sensitivity to the effects of 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats.
    The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:6

    Topics: Acoustic Stimulation; Aging; Animals; Animals, Newborn; Behavior, Animal; Biogenic Monoamines; Body

2012
Sex-dependent effects of early maternal deprivation on MDMA-induced conditioned place preference in adolescent rats: possible neurochemical correlates.
    Toxicology, 2013, Sep-06, Volume: 311, Issue:1-2

    Topics: Aging; Animals; Brain; Brain Chemistry; Conditioning, Classical; Female; Male; Maternal Deprivation;

2013
Increased anxiety-related behavior in male and female adult rats following early and late adolescent exposure to 3,4-methylenedioxymethamphetamine (MDMA).
    Pharmacology, biochemistry, and behavior, 2013, Volume: 103, Issue:4

    Topics: Age Factors; Aging; Animals; Anxiety; Female; Male; Maze Learning; N-Methyl-3,4-methylenedioxyamphet

2013
Acute and carryover effects in mice of MDMA ("ecstasy") administration during periadolescence.
    European journal of pharmacology, 2002, Jul-12, Volume: 448, Issue:1

    Topics: Aging; Animals; Behavior, Animal; Female; Hallucinogens; Hypothalamus; Locomotion; Male; Mice; N-Met

2002
Age-dependent (+)MDMA-mediated neurotoxicity in mice.
    Neurotoxicology, 2005, Volume: 26, Issue:6

    Topics: Aging; Animals; Body Temperature; Brain; Dopamine Plasma Membrane Transport Proteins; Fever; Halluci

2005
Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 317, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aging; Animals; Behavior, Animal; Body Weight; Dose-Response

2006
The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?
    Human psychopharmacology, 2006, Volume: 21, Issue:6

    Topics: Age Factors; Aging; Cognition; Drug Interactions; Educational Status; Female; Hallucinogens; Humans;

2006
Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain.
    Neurotoxicology, 2007, Volume: 28, Issue:6

    Topics: Age Factors; Aging; Animals; Autoradiography; Behavior, Animal; Brain; Central Nervous System Stimul

2007
Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats.
    BMC neuroscience, 2008, Apr-17, Volume: 9

    Topics: Adaptation, Physiological; Adrenergic Uptake Inhibitors; Age Factors; Aging; Amphetamine-Related Dis

2008
Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:1

    Topics: Aging; Animals; Body Temperature Regulation; Brain; Dose-Response Relationship, Drug; Female; Male;

1995
Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain.
    Annals of the New York Academy of Sciences, 2002, Volume: 965

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Apoptosis; Brain; Dopamine; Female; Homovanillic Aci

2002